BlueRun Ventures ranked TOP 2 in the 2022 China FOF Research Center Early-Stage Fund Best Returns ranking, and TOP 50 in Best Returns Direct Investment Fund Investors.
Sustained Investment in Technological Innovation
In 2022, China's equity investment industry faced new challenges. Under this new landscape, the industry was reshaping its structure, with LP-GP collaboration models continuously adjusting and evolving. Against this backdrop, the China FOF Research Center (www.china-fof.com), drawing on its existing data and research analysis, officially released its mid-2022 rankings on July 31, 2022, to recognize outstanding institutions and individuals in the private equity fund-of-funds and fund industries, and to promote the healthy development of equity investment. BlueRun Ventures received the following honors:
- Top 30 Early-Stage Funds by Returns 2022, ranked #2
- Managing Partner Jui Chan: Top 50 Direct Investment Investors by Returns 2022
Further Reading
BlueRun Ventures was founded in 1998 in Silicon Valley. BlueRun Ventures China was established in 2005 and is a venture capital firm focused on early-stage startups.
Currently, BlueRun Ventures China manages multiple USD and RMB dual-currency funds, with assets under management exceeding RMB 15 billion, making it one of the largest early-stage funds in China. The firm invests primarily at the Pre-A and Series A stages, covering hard tech and innovative interaction, enterprise technology, new consumer, and healthcare sectors. It has made over 150 investments in startup companies, including Li Auto, Waterdrop, QingCloud, Guazi.com, Qudian, Songguo, Ganji.com, Energy Monster, Yuntu Semiconductor, Machenike, Yunsheng AI, Anxin Wangdun, and BioMap.
BlueRun Ventures has been ranked #1 among "China's Top 30 Early-Stage Investment Institutions" by Zero2IPO and #1 among "China's Best Early-Stage Venture Capital Institutions TOP30" by ChinaVenture, and was named to Preqin's Top 10 VC Fund Managers Globally for Sustained High Returns.
Additionally, BlueRun Ventures has received consecutive annual recognition from media outlets including Forbes China, 36Kr, Cyzone, Caixin Media, CBNweekly, and Jiemian, earning titles such as "China's Best Early-Stage Firm of the Year," "China's Top Venture Capital Firm," "Most Founder-Friendly Early-Stage Firm of the Year," and "Most Influential Early-Stage Firm of the Year."